I’m looking for information (publication or gray-literature) on the benefits of openEHR based Open Platforms vs Big EMR / Monoliths from an economical evaluation/benchmarking /ROI perspective. It could be any sort of material, web pages, whitepapers, LinkedIn posts, blogs etc. Possibly part of digital transformation strategies, roadmaps, RFI/RFPs and more. Of course our vendors will have done such analyses and have such materials - but most likely internal. If they can also share some they’d feel comfortable with it’d be amazing and prevent us to re-analyse and re-invent 
We often talk about this (well a lot in fact!) but it’d be good to arm ourselves with evidence / data! I’m planning to prepare a business case and would really appreciate community input.
@erik.sundvall @ian.mcnicoll @ukpenguin @TomazG @stefan.schraps @lukas.eksteen @sebastian.iancu @Rong_Chen @Monty @Alastair